<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33446423</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0968-0004</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>7</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Trends in biochemical sciences</Title><ISOAbbreviation>Trends Biochem Sci</ISOAbbreviation></Journal><ArticleTitle>FUS and TDP-43 Phases in Health and Disease.</ArticleTitle><Pagination><StartPage>550</StartPage><EndPage>563</EndPage><MedlinePgn>550-563</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tibs.2020.12.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0968-0004(20)30313-3</ELocationID><Abstract><AbstractText>The distinct prion-like domains (PrLDs) of FUS and TDP-43, modulate phase transitions that result in condensates with a range of material states. These assemblies are implicated in both health and disease. In this review, we examine how sequence, structure, post-translational modifications, and RNA can affect the self-assembly of these RNA-binding proteins (RBPs). We discuss how our emerging understanding of FUS and TDP-43 liquid-liquid phase separation (LLPS) and aggregation, could be leveraged to design new therapies for neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and limbic-predominant age-related TDP-43 encephalopathy (LATE).</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Portz</LastName><ForeName>Bede</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Bo Lim</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorter</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: jshorter@pennmedicine.upenn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM099836</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG061784</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG065854</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Biochem Sci</MedlineTA><NlmUniqueID>7610674</NlmUniqueID><ISSNLinking>0968-0004</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aggregation</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">phase separation</Keyword><Keyword MajorTopicYN="N">prion-like domains: RNA-binding proteins</Keyword><Keyword MajorTopicYN="N">stress granules</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>15</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33446423</ArticleId><ArticleId IdType="mid">NIHMS1674618</ArticleId><ArticleId IdType="pmc">PMC8195841</ArticleId><ArticleId IdType="doi">10.1016/j.tibs.2020.12.005</ArticleId><ArticleId IdType="pii">S0968-0004(20)30313-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boeynaems S et al. (2018) Protein phase separation: a new phase in cell biology. Trends Cell Biol. 28, 420&#x2013;435</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6034118</ArticleId><ArticleId IdType="pubmed">29602697</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudyal RR et al. (2018) Physical principles and extant biology reveal roles for RNA-containing membraneless compartments in origins of life chemistry. Biochemistry 57, 2509&#x2013;2519</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276092</ArticleId><ArticleId IdType="pubmed">29560725</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne CP et al. (2009) Germline P granules are liquid droplets that localize by controlled dissolution/condensation. Science 324, 1729&#x2013;1732</Citation><ArticleIdList><ArticleId IdType="pubmed">19460965</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman AA et al. (2014) Liquid-liquid phase separation in biology. Annu. Rev. Cell Dev. Biol 30, 39&#x2013;58</Citation><ArticleIdList><ArticleId IdType="pubmed">25288112</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbaum-Garfinkle S and Brangwynne CP (2015) Liquids, fibers, and gels: the many phases of neurodegeneration. Dev. Cell 35, 531&#x2013;532</Citation><ArticleIdList><ArticleId IdType="pubmed">26651288</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P et al. (2012) Phase transitions in the assembly of multivalent signalling proteins. Nature 483, 336&#x2013;340</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3343696</ArticleId><ArticleId IdType="pubmed">22398450</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin EW and Mittag T (2018) Relationship of sequence and phase separation in protein low-complexity regions. Biochemistry 57, 2478&#x2013;2487</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6476794</ArticleId><ArticleId IdType="pubmed">29517898</ArticleId></ArticleIdList></Reference><Reference><Citation>Pak CW et al. (2016) Sequence determinants of intracellular phase separation by complex coacervation of a disordered protein. Mol. Cell 63, 72&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4973464</ArticleId><ArticleId IdType="pubmed">27392146</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle M et al. (2019) Inherited and sporadic amyotrophic lateral sclerosis and fronto-temporal lobar degenerations arising from pathological condensates of phase separating proteins. Hum. Mol. Genet 28, R187&#x2013;R196</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6872449</ArticleId><ArticleId IdType="pubmed">31595953</ArticleId></ArticleIdList></Reference><Reference><Citation>St George-Hyslop P et al. (2018) The physiological and pathological biophysics of phase separation and gelation of RNA binding proteins in amyotrophic lateral sclerosis and fronto-temporal lobar degeneration. Brain Res. 1693, 11&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6018615</ArticleId><ArticleId IdType="pubmed">29723523</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmon TS et al. (2017) Intrinsically disordered linkers determine the interplay between phase separation and gelation in multivalent proteins. Elife 6, e30294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5703641</ArticleId><ArticleId IdType="pubmed">29091028</ArticleId></ArticleIdList></Reference><Reference><Citation>March ZM et al. (2016) Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res. 1647, 9&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003744</ArticleId><ArticleId IdType="pubmed">26996412</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AF and Shorter J (2017) RNA-binding proteins with prion-like domains in health and disease. Biochem. J 474, 1417&#x2013;1438</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5639257</ArticleId><ArticleId IdType="pubmed">28389532</ArticleId></ArticleIdList></Reference><Reference><Citation>King OD et al. (2012) The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 1462, 61&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372647</ArticleId><ArticleId IdType="pubmed">22445064</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YR et al. (2013) Stress granules as crucibles of ALS pathogenesis. J. Cell Biol 201, 361&#x2013;372</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady JP et al. (2017) Structural and hydrodynamic properties of an intrinsically disordered region of a germ cell-specific protein on phase separation. Proc. Natl. Acad. Sci. U. S. A 114, E8194&#x2013;E8203</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5625912</ArticleId><ArticleId IdType="pubmed">28894006</ArticleId></ArticleIdList></Reference><Reference><Citation>Holehouse AS and Pappu RV (2018) Functional implications of intracellular phase transitions. Biochemistry 57, 2415&#x2013;2423</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6538385</ArticleId><ArticleId IdType="pubmed">29323488</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A et al. (2018) A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 37, e97452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z et al. (2017) Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 36, 2951&#x2013;2967</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz JC et al. (2013) RNA seeds higher-order assembly of FUS protein. Cell Rep. 5, 918&#x2013;925</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3925748</ArticleId><ArticleId IdType="pubmed">24268778</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke KA et al. (2015) Residue-by-residue view of in vitro FUS granules that bind the C-terminal domain of RNA polymerase II. Mol. Cell 60, 231&#x2013;241</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609301</ArticleId><ArticleId IdType="pubmed">26455390</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L et al. (2018) Poly(ADP-Ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol. Cell 71, 703&#x2013;717.e9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128762</ArticleId><ArticleId IdType="pubmed">30100264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H et al. (2015) RNA controls polyQ protein phase transitions. Mol. Cell 60, 220&#x2013;230</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5221516</ArticleId><ArticleId IdType="pubmed">26474065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT et al. (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142, 1503&#x2013;1527</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y et al. (2015) Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol. Cell 60, 208&#x2013;219</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609299</ArticleId><ArticleId IdType="pubmed">26412307</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S et al. (2016) ATPase-modulated stress granules contain a diverse proteome and substructure. Cell 164, 487&#x2013;498</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4733397</ArticleId><ArticleId IdType="pubmed">26777405</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S et al. (2018) Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell 172, 590&#x2013;604.e13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J-M et al. (2019) LASSI: A lattice model for simulating phase transitions of multivalent proteins. PLoS Comput. Biol 15, e1007028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6822780</ArticleId><ArticleId IdType="pubmed">31634364</ArticleId></ArticleIdList></Reference><Reference><Citation>Riback JA et al. (2020) Composition-dependent thermodynamics of intracellular phase separation. Nature 581, 209&#x2013;214</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7733533</ArticleId><ArticleId IdType="pubmed">32405004</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A et al. (2015) A Liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162, 1066&#x2013;1077</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung AKL (2020) Poly(ADP-ribose): a dynamic trigger for biomolecular condensate formation. Trends Cell Biol. 30, 370&#x2013;383</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326565</ArticleId><ArticleId IdType="pubmed">32302549</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR et al. (2019) RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron 102, 321&#x2013;338.e8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang MY et al. (2019) Small-molecule modulation of TDP-43 recruitment to stress granules prevents persistent TDP-43 accumulation in ALS/FTD. Neuron 103, 802&#x2013;819.e11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6728177</ArticleId><ArticleId IdType="pubmed">31272829</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y et al. (2017) Spatiotemporal control of intracellular phase transitions using light-activated optoDroplets. Cell 168, 159&#x2013;171.e14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5562165</ArticleId><ArticleId IdType="pubmed">28041848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C-E and Tsai K-J (2019) TDP-43 proteinopathy impairs neuronal mRNP granule mediated postsynapticlocal translation and mRNA metabolism. bioRxiv 10.1101/589416 Published online April 04,2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/589416</ArticleId><ArticleId IdType="pmc">PMC7681104</ArticleId><ArticleId IdType="pubmed">33391478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciryam P et al. (2017) Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. Proc. Natl. Acad. Sci 114, E3935&#x2013;E3943</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441770</ArticleId><ArticleId IdType="pubmed">28396410</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A et al. (2015) Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163, 123&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong A et al. (2017) The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. Mol. Cell 68, 808&#x2013;820.e5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5728175</ArticleId><ArticleId IdType="pubmed">29129640</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L et al. (2018) Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell 173, 677&#x2013;692.e20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Banani SF et al. (2016) Compositional control of phase-separated cellular bodies. Cell 166, 651&#x2013;663</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4967043</ArticleId><ArticleId IdType="pubmed">27374333</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders DW et al. (2020) Competing protein-RNA interaction networks control multiphase intracellular organization. Cell 181, 306&#x2013;324.e28</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816278</ArticleId><ArticleId IdType="pubmed">32302570</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P et al. (2020) G3BP1 is a tunable switch that triggers phase separation to assemble stress granules. Cell 181, 325&#x2013;345.e28</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448383</ArticleId><ArticleId IdType="pubmed">32302571</ArticleId></ArticleIdList></Reference><Reference><Citation>McSwiggen DT et al. (2019) Evaluating phase separation in live cells: diagnosis, caveats, and functional consequences. Genes Dev. 33, 1619&#x2013;1634</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6942051</ArticleId><ArticleId IdType="pubmed">31594803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A and Buratti E (2016) Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem 138, 95&#x2013;111</Citation><ArticleIdList><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S-C et al. (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416&#x2013;438</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J et al. (2018) A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins. Cell 174, 688&#x2013;699.e16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063760</ArticleId><ArticleId IdType="pubmed">29961577</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z et al. (2011) Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 9, e1000614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S et al. (2018) FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-&#x3c0; interactions. Cell 173, 720&#x2013;734.e15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdilek BA et al. (2017) Intrinsically disordered RGG/RG domains mediate degenerate specificity in RNA binding. Nucleic Acids Res. 45, 7984&#x2013;7996</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5570134</ArticleId><ArticleId IdType="pubmed">28575444</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong PA et al. (2018) RGG/RG motif regions in RNA binding and phase separation. J. Mol. Biol 430, 4650&#x2013;4665</Citation><ArticleIdList><ArticleId IdType="pubmed">29913160</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S et al. (2018) RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science 360, 918&#x2013;921</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray DT et al. (2017) Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell 171, 615&#x2013;627</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo F et al. (2018) Atomic structures of FUS LC domain segments reveal bases for reversible amyloid fibril formation. Nat. Struct. Mol. Biol 25, 341&#x2013;346</Citation><ArticleIdList><ArticleId IdType="pubmed">29610493</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes MP et al. (2018) Atomic structures of low-complexity protein segments reveal kinked &#x3b2; sheets that assemble networks. Science 359, 698&#x2013;701</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6192703</ArticleId><ArticleId IdType="pubmed">29439243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrocola AS et al. (2013) The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage. J. Biol. Chem 288, 24731&#x2013;24741</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3750169</ArticleId><ArticleId IdType="pubmed">23833192</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmeyer M et al. (2015) Liquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose). Nat. Commun 6, 8088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4560800</ArticleId><ArticleId IdType="pubmed">26286827</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa T et al. (2018) Nuclear import receptor inhibits phase separation of FUS through binding to multiple sites. Cell 173, 693&#x2013;705.e22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234985</ArticleId><ArticleId IdType="pubmed">29677513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M et al. (2018) Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell 173, 706&#x2013;719.e13</Citation><ArticleIdList><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Niaki AG et al. (2020) Loss of dynamic RNA interaction and aberrant phase separation induced by two distinct types of ALS/FTD-linked FUS mutations. Mol. Cell 77, 82&#x2013;94.e4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6943187</ArticleId><ArticleId IdType="pubmed">31630970</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhine K et al. (2020) ALS/FTLD-linked mutations in FUS glycine residues cause accelerated gelation and reduced interactions with wild-type FUS. Mol. Cell 80, 666&#x2013;681</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7688085</ArticleId><ArticleId IdType="pubmed">33159856</ArticleId></ArticleIdList></Reference><Reference><Citation>Darovic S et al. (2015) Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import. J. Cell Sci 128, 4151&#x2013;4159</Citation><ArticleIdList><ArticleId IdType="pubmed">26403203</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoads SN et al. (2018) The role of post-translational modifications on prion-like aggregation and liquid-phase separation of FUS. Int. J. Mol. Sci 19, 886</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5877747</ArticleId><ArticleId IdType="pubmed">29547565</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloutsky R and Naegle KM (2018) Proteome-level analysis indicates global mechanisms for post-translational regulation of RRM domains. J. Mol. Biol 430, 41&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pubmed">29146174</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen I et al. (2020) The prion-like domain of fused in sarcoma is phosphorylated by multiple kinases affecting liquid-and solid-phase transitions. Mol. Biol. Cell 31, 2522&#x2013;2536</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7851872</ArticleId><ArticleId IdType="pubmed">32877292</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F et al. (2019) Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102, 339&#x2013;357.e7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogler TO et al. (2018) TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle. Nature 563, 508&#x2013;513</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324568</ArticleId><ArticleId IdType="pubmed">30464263</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y et al. (2013) The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol. Brain 6, 31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3729541</ArticleId><ArticleId IdType="pubmed">23835137</ArticleId></ArticleIdList></Reference><Reference><Citation>Udan-Johns M et al. (2014) Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Hum. Mol. Genet 23, 157&#x2013;170</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3857952</ArticleId><ArticleId IdType="pubmed">23962724</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L et al. (2018) Poly(ADP-ribose) engages the TDP-43 nuclear-localization sequence to regulate granulo-filamentous aggregation. Biochemistry 57, 6923&#x2013;6926</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6752045</ArticleId><ArticleId IdType="pubmed">30540446</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS et al. (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem 284, 20329&#x2013;20339</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E (2015) Functional significance of TDP-43 mutations in disease. Adv. Genet 91, 1&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">26410029</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E et al. (2012) Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). J. Biol. Chem 287, 23079&#x2013;23094</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3391091</ArticleId><ArticleId IdType="pubmed">22563080</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin EW et al. (2020) Valence and patterning of aromatic residues determine the phase behavior of prion-like domains. Science 367, 694&#x2013;699</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7297187</ArticleId><ArticleId IdType="pubmed">32029630</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L-L et al. (2017) The N-terminal dimerization is required for TDP-43 splicing activity. Sci. Rep 7, 6196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5522446</ArticleId><ArticleId IdType="pubmed">28733604</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T et al. (2017) Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun 8, 45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt HB et al. (2019) Phase separation-deficient TDP43 remains functional in splicing. Nat. Commun 10, 4890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6814767</ArticleId><ArticleId IdType="pubmed">31653829</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE et al. (2020) TDP-43 &#x3b1;-helical structure tunes liquid&#x2013;liquid phase separation and function. Proc. Natl. Acad Sci. U.S.A 117, 5883&#x2013;5894</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7084079</ArticleId><ArticleId IdType="pubmed">32132204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim L et al. (2016) ALS-causing mutations significantly perturb the self-assembly and interaction with nucleic acid of the intrinsically disordered prion-like domain of TDP-43. PLoS Biol. 14, e1002338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4703307</ArticleId><ArticleId IdType="pubmed">26735904</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE et al. (2016) ALS mutations disrupt phase separation mediated by &#x3b1;-helical structure in the TDP-43 low-complexity C-terminal domain. Structure 24, 1537&#x2013;1549</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y et al. (2020) Redox-mediated regulation of an evolutionarily conserved cross-&#x3b2; structure formed by the TDP43 low complexity domain. Proc. Natl. Acad. Sci. U. S. A 117, 28727&#x2013;28734</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682574</ArticleId><ArticleId IdType="pubmed">33144500</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H-R et al. (2018) TAR DNA-binding protein 43 (TDP-43) liquid&#x2013;liquid phase separation is mediated by just a few aromatic residues. J. Biol. Chem 293, 6090&#x2013;6098</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5912450</ArticleId><ArticleId IdType="pubmed">29511089</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenther EL et al. (2018) Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nat. Struct. Mol. Biol 25, 463&#x2013;471</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5990464</ArticleId><ArticleId IdType="pubmed">29786080</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M et al. (2009) Phosphorylation of S409/410 of TDP-43 is a consistent feature in allsporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117, 137&#x2013;149</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ et al. (2015) An acetylation switch controls TDP-43 function and aggregation propensity. Nat. Commun 6, 5845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H et al. (2020) HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells. Science, eabb4309 10.1126/science.abb4309</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb4309</ArticleId><ArticleId IdType="pmc">PMC8286096</ArticleId><ArticleId IdType="pubmed">33335017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P et al. (2019) Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology. Elife 8, e39578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6426440</ArticleId><ArticleId IdType="pubmed">30893049</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C-C et al. (2018) TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/ FTD. Nat. Neurosci 21, 228&#x2013;239</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S et al. (2020) Nuclear import receptors directly bind to arginine-rich dipeptide repeat prtoeins and suppress their pathologicalinteractions. Cell Rep. 33, 108538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7814465</ArticleId><ArticleId IdType="pubmed">33357437</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal PP et al. (2017) Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proc. Natl. Acad. Sci 114, E2466&#x2013;E2475</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373408</ArticleId><ArticleId IdType="pubmed">28265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ et al. (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467&#x2013;473</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC et al. (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069&#x2013;1075</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackrel ME et al. (2014) Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell 156, 170&#x2013;182</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3909490</ArticleId><ArticleId IdType="pubmed">24439375</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariq A et al. (2018) Potentiating Hsp104 activity via phosphomimetic mutations in the middle domain. FEMS Yeast Res. 18, foy042</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454557</ArticleId><ArticleId IdType="pubmed">29788207</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariq A et al. (2019) Mining disaggregase sequence space to safely counter TDP-43, FUS, and &#x3b1;-synuclein proteotoxicity. Cell Rep. 28 e6, 2080&#x2013;2095</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6750954</ArticleId><ArticleId IdType="pubmed">31433984</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognesi B et al. (2019) The mutational landscape of a prion-like domain. Nat. Commun 10, 4162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6744496</ArticleId><ArticleId IdType="pubmed">31519910</ArticleId></ArticleIdList></Reference><Reference><Citation>Riback JA et al. (2017) Stress-triggered phase separation is an adaptive, evolutionarily tuned response. Cell 168, 1028&#x2013;1040.e19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5401687</ArticleId><ArticleId IdType="pubmed">28283059</ArticleId></ArticleIdList></Reference><Reference><Citation>Guill&#xe9;n-Boixet J et al. (2020) RNA-induced conformational switching and clustering of G3BP drive stress granule assembly by condensation. Cell 181, 346&#x2013;361.e17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7181197</ArticleId><ArticleId IdType="pubmed">32302572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F et al. (2020) Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules. J. Biol. Chem 295, 673&#x2013;689</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970928</ArticleId><ArticleId IdType="pubmed">31780563</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S and Gitler AD (2018) Pour some sugar on TDP(&#x2212;43). Mol. Cell 71, 649&#x2013;651</Citation><ArticleIdList><ArticleId IdType="pubmed">30193092</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J et al. (2020) Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency. Nature Published online August 31, 2020. 10.1038/s41586-020-2709-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2709-7</ArticleId><ArticleId IdType="pmc">PMC7746606</ArticleId><ArticleId IdType="pubmed">32866962</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan A et al. (2019) A first order phase transition mechanism underlies protein aggregation in mammalian cells. Elife 8, e39695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6361590</ArticleId><ArticleId IdType="pubmed">30716021</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackrel ME and Shorter J (2015) Engineering enhanced protein disaggregases for neurodegenerative disease. Prion 9, 90&#x2013;109</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4601286</ArticleId><ArticleId IdType="pubmed">25738979</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J (2016) Engineering therapeutic protein disaggregases. Mol. Biol. Cell 27, 1556&#x2013;1560</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4865313</ArticleId><ArticleId IdType="pubmed">27255695</ArticleId></ArticleIdList></Reference><Reference><Citation>Cupo RR and Shorter J (2020) Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations. Elife 9, e55279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7343390</ArticleId><ArticleId IdType="pubmed">32573439</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH et al. (2014) Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81, 536&#x2013;543</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B et al. (2019) ULK1 and ULK2 regulate stress granule disassembly through phosphorylation and activation of VCP/ p97. Mol. Cell 74, 742&#x2013;757.e8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6859904</ArticleId><ArticleId IdType="pubmed">30979586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroschwald S et al. (2015) Promiscuous interactions and protein disaggregases determine the material state of stress-inducible RNP granules. Elife 4, e06807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4522596</ArticleId><ArticleId IdType="pubmed">26238190</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan JR et al. (2013) Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 153, 1461&#x2013;1474</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760148</ArticleId><ArticleId IdType="pubmed">23791177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y et al. (2016) Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers. Cell 167, 789&#x2013;802.e12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5076566</ArticleId><ArticleId IdType="pubmed">27768897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribbeck K and G&#xf6;rlich D (2002) The permeability barrier of nuclear pore complexes appears to operate via hydrophobic exclusion. EMBO J. 21, 2664&#x2013;2671</Citation><ArticleIdList><ArticleId IdType="pmc">PMC126029</ArticleId><ArticleId IdType="pubmed">12032079</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroschwald S et al. (2017) Hexanediol: a chemical probe to investigate the material properties of membrane-less compartments. Matters Published online May 22, 2017. 10.19185/matters.201702000010</Citation><ArticleIdList><ArticleId IdType="doi">10.19185/matters.201702000010</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A et al. (2017) ATP as a biological hydrotrope. Science 356, 753&#x2013;756</Citation><ArticleIdList><ArticleId IdType="pubmed">28522535</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler RJ et al. (2019) Small molecules for modulating protein driven liquid-liquid phase separation in treating neurodegenerative disease. BioRxiv Published online August 21, 2019. 10.1101/721001</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/721001</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinchak WM et al. (2020) Small molecules as potent biphasic modulators of protein liquid-liquid phase separation. Nat. Commun 11, 5574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7643064</ArticleId><ArticleId IdType="pubmed">33149109</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois-Moutal L et al. (2019) Small molecule targeting TDP-43&#x2019;s RNA recognition motifs reduces locomotor defects in a Drosophila model of amyotrophic lateral sclerosis (ALS). ACS Chem. Biol 14, 2006&#x2013;2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6911355</ArticleId><ArticleId IdType="pubmed">31241884</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollasalehi N et al. (2020) An allosteric modulator of RNA binding targeting the N-terminal domain of TDP-43 yields neuroprotective properties. ACS Chem. Biol 15, 2854&#x2013;2859</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8548910</ArticleId><ArticleId IdType="pubmed">33044808</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein IA et al. (2020) Partitioning of cancer therapeutics in nuclear condensates. Science 368, 1386&#x2013;1392</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7735713</ArticleId><ArticleId IdType="pubmed">32554597</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J and Lindquist S (2005) Prions as adaptive conduits of memory and inheritance. Nat. Rev. Genet 6, 435&#x2013;450</Citation><ArticleIdList><ArticleId IdType="pubmed">15931169</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A and De Cecco E (2020) Shifts and drifts in prion science. Science 370, 32&#x2013;34</Citation><ArticleIdList><ArticleId IdType="pubmed">33004500</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M et al. (2010) Prion-like disorders: blurring the divide between transmissibility and infectivity. J. Cell Sci 123, 1191&#x2013;1201</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2848109</ArticleId><ArticleId IdType="pubmed">20356930</ArticleId></ArticleIdList></Reference><Reference><Citation>Newby GA and Lindquist S (2013) Blessings in disguise: biological benefits of prion-like mechanisms. Trends Cell Biol 23, 251&#x2013;259</Citation><ArticleIdList><ArticleId IdType="pubmed">23485338</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty AK and Jarosz DF (2018) More than just a phase: prions at the crossroads of epigenetic inheritance and evolutionary change. J. Mol. Biol 430, 4607&#x2013;4618</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6204307</ArticleId><ArticleId IdType="pubmed">30031007</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarosz DF et al. (2014) Cross-kingdom chemical communication drives a heritable, mutually beneficial prion-based transformation of metabolism. Cell 158, 1083&#x2013;1093</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4424051</ArticleId><ArticleId IdType="pubmed">25171409</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarosz DF et al. (2014) An evolutionarily conserved prion-like element converts wild fungi from metabolic specialists to generalists. Cell 158, 1072&#x2013;1082</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4424049</ArticleId><ArticleId IdType="pubmed">25171408</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey ZH et al. (2020) A prion epigenetic switch establishes an active chromatin state. Cell 180, 928&#x2013;940.e14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195540</ArticleId><ArticleId IdType="pubmed">32109413</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster AK et al. (2014) PLAAC: a web and command-line application to identify proteins with prion-like amino acid composition. Bioinformatics 30, 2501&#x2013;2502</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4147883</ArticleId><ArticleId IdType="pubmed">24825614</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty AK et al. (2020) A non-amyloid prion particle that activates a heritable gene expression program. Mol. Cell 77, 251&#x2013;265.e9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6980676</ArticleId><ArticleId IdType="pubmed">31757755</ArticleId></ArticleIdList></Reference><Reference><Citation>Han TW et al. (2012) Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell 149, 768&#x2013;779</Citation><ArticleIdList><ArticleId IdType="pubmed">22579282</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S et al. (2018) Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun 9, 4220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T et al. (2013) Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 4, 124&#x2013;134</Citation><ArticleIdList><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferri&#xe8;re F et al. (2019) TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat. Neurosci 22, 65&#x2013;77</Citation><ArticleIdList><ArticleId IdType="pubmed">30559480</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobson CM and Jarosz DF (2018) Organizing biochemistry in space and time using prion-like self-assembly. Curr. Opin. Syst. Biol 8, 16&#x2013;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5926789</ArticleId><ArticleId IdType="pubmed">29725624</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfmann R (2016) A glass menagerie of low complexity sequences. Curr. Opin. Struct. Biol 38, 18&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5010471</ArticleId><ArticleId IdType="pubmed">27258703</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakrabortee S et al. (2016) Intrinsically disordered proteins drive emergence and inheritance of biological traits. Cell 167, 369&#x2013;381.e12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5066306</ArticleId><ArticleId IdType="pubmed">27693355</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeples W and Rosen MK (2020) Phase separation can increase enzyme activity by concentration and molecular organization. bioRxiv Published online September 17, 2020. 10.1101/2020.09.15.299115</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.15.299115</ArticleId></ArticleIdList></Reference><Reference><Citation>Loring HS and Thompson PR (2020) A liquid-to-solid phase transition enhances the catalytic activity of SARM1. bioRxiv Published online August 29, 2020. 10.1101/2020.08.28.272377</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.28.272377</ArticleId></ArticleIdList></Reference><Reference><Citation>Leavitt BR and Tabrizi SJ (2020) Antisense oligonucleotides for neurodegeneration. Science 367, 1428&#x2013;1429</Citation><ArticleIdList><ArticleId IdType="pubmed">32217715</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C et al. (2020) Stress induces dynamic, cytotoxicity-antagonizing TDP-43 nuclear bodies via paraspeckle LncRNA NEAT1-mediated liquid-liquid phase separation. Mol. Cell 79, 443&#x2013;458.e7</Citation><ArticleIdList><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>